Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Thread Formerly Known as No Rest For The Wicked -- Ignore unavailable to you. Want to Upgrade?

To: rodney beasley who wrote (12646)	2/9/1999 9:54:00 AM
From: A. Charles	Read Replies (1) \| Respond to of 90042

IGEN....Position players might want to check out this biotech; off from peaks of several weeks and months ago. Recent decline attributed by local business press to resignation of Montgomery analyst (he moved to a NY hedge fund) rather than change in company. Technology looks great to me, and company has continued to extend its string of licensing agreements with bigger guys. I'm in at mid-20s and looking for 30 near-term, possibly back to 40 when (1) biotech resumes its return to favor, (2) people start looking for places to park cash and consequently (3) the volume picks up....all imho, of course; DD required. Cheers, ac